CLINICAL_TRIALS ClinicalTrials.gov record update

Non-inferiority of One Formulation of GSK Biologicals' DTPw-HBV/Hib to 2 Formulations of GSK Biologicals' DTPw-HBV/Hib With Respect to the Immune Response to the PRP Antigen, When Administered to Healthy Infants at 6, 10, 14 Weeks of Age

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00473668
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:28.354580+00:00
Published At: 2017-08-18T00:00:00+00:00
Record Updated At: 2017-08-18
Results Posted At: 2017-08-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Whole Cell Pertussis", "Haemophilus Influenzae Type b", "Tetanus", "Diphtheria", "Hepatitis B"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-08-18"
protocolSection.identificationModule.nctId: "NCT00473668"
protocolSection.identificationModule.officialTitle: "Non-inferiority of One Formulation of GSK Biologicals\u0027 DTPw-HBV/Hib to 2 Formulations of GSK Biologicals\u0027 DTPw-HBV/Hib With Respect to the Immune Response to the PRP Antigen, When Administered to Healthy Infants at 6, 10, 14 Weeks of Age"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-08-18"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.